New Perspectives in Management of Cardiovascular Risk Among People With DiabetesJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32024-06-182OAAI
The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is betterAMERICAN JOURNAL OF PREVENTIVE CARDIOLOGYIF5.92024-06-0122OA
PREVENT Equations: A New Era in Cardiovascular Disease Risk AssessmentCIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMESIF6.72024-04-011PRE
Metaplastic Breast Cancer: Treatment and Prognosis in a University Hospital over a 20 year periodEUROPEAN JOURNAL OF CANCERIF7.12024-03-010PRE
COVID's Impact on Non-communicable Diseases: What We Do Not Know May Hurt UsCURRENT CARDIOLOGY REPORTSIF3.32022-05-0713OAAI
Surfing the Waves of the COVID-19 Pandemic as a Cardiovascular ClinicianCIRCULATIONIF38.62020-07-1428PREAI
Popular Media and Cardiovascular Medicine: with Great Power There Must Also Come Great ResponsibilityCURRENT ATHEROSCLEROSIS REPORTSIF5.22019-10-319PREAI
Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical TrialsCURRENT ATHEROSCLEROSIS REPORTSIF5.22019-01-1027PRE
Hypertriglyceridemia: A simple approach to identify insulin resistance and enhanced cardio-metabolic risk in patients with prediabetesDIABETES RESEARCH AND CLINICAL PRACTICEIF7.42016-10-0119PREAI
HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent PCSK9-Lipid ParadoxJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32016-05-0642OAAI
Cardiovascular Imaging of Women We Have Come a Long Way But Still Have a Ways to GoJACC-CARDIOVASCULAR IMAGINGIF15.22016-04-010OAAI
Clinician's Guide to the Updated ABCs of Cardiovascular Disease PreventionJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32014-09-1625OAAI
Clinical Trial Participation After Myocardial Infarction in a National Cardiovascular Data RegistryJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552014-08-2741PREAI
Looking for Coronary Disease in Patients With Atrial FibrillationCANADIAN JOURNAL OF CARDIOLOGYIF5.32014-08-014OAAI
Nonfatal Outcomes in the Primary Prevention of Atherosclerotic Cardiovascular Disease Is All-Cause Mortality Really All That Matters?CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMESIF6.72014-05-013OAAI
Vini, Vidi, Vici ... Restructured Format for Condensed AbstractsJACC-CARDIOVASCULAR IMAGINGIF15.22013-11-010OAAI
AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy: An Analysis From the LDL-C Assessment With Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined With Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 TrialCIRCULATIONIF38.62013-08-27163OAAI
Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO StudyPLATO研究中替格瑞洛与氯吡格雷相比首次和复发心血管事件的减少CIRCULATIONIF38.62013-02-1273OA
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 studyLANCETIF88.52012-12-01408OAAI
Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromesEXPERT OPINION ON DRUG METABOLISM & TOXICOLOGYIF3.42012-05-114PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向